dinoprost has been researched along with Alopecia* in 4 studies
2 review(s) available for dinoprost and Alopecia
Article | Year |
---|---|
Promising alternative clinical uses of prostaglandin F2α analogs: beyond the eyelashes.
Prostaglandin F2α analogs, commonly prescribed for glaucoma treatment, have been shown to induce side effects such as cutaneous hypertrichosis and hyperpigmentation. Therefore, these medications have theoretic applications in the treatment of alopecia and disorders of hypopigmentation. We reviewed the literature to find original studies assessing the use of prostaglandin F2α analogs in these settings. Studies and reports were analyzed in regards to androgenic alopecia, alopecia areata, chemotherapy-induced alopecia, vitiligo, and hypopigmented scarring. Based on the results of these studies, and consideration of pathophysiologic mechanism, the most promising applications for prostaglandin F2α analogs include androgenic alopecia, chemotherapy-induced alopecia, and alopecia areata concurrently treated with corticosteroids. Topics: Adrenal Cortex Hormones; Alopecia; Amides; Animals; Bimatoprost; Cloprostenol; Dinoprost; Disease Models, Animal; Double-Blind Method; Drug Evaluation, Preclinical; Eyelashes; Glaucoma; Hair Follicle; Humans; Hyperpigmentation; Hypertrichosis; Hypopigmentation; Melanins; Mice; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Retrospective Studies; Single-Blind Method | 2015 |
Emerging Therapies for Androgenetic Alopecia.
Androgenetic alopecia is the progressive miniaturization of the scalp's terminal follicles in aging men. Over 40% of Caucasian men develop hair loss by the age of 40. Despite its prevalence, there are only two FDA approved medications to treat the condition. Recognizing the unmet need, new medical, procedural, and surgical treatments are being adopted to combat progressive hair loss. This review examines emerging hair loss treatments including medical therapies that the target prostaglandins, low level light therapy, platelet rich plasma injections, and robotic hair transplantation. Topics: Alopecia; Dinoprost; Hair Follicle; Humans; Low-Level Light Therapy; Male; Platelet-Rich Plasma; Prostaglandin D2; Prostaglandins; Robotic Surgical Procedures | 2015 |
2 other study(ies) available for dinoprost and Alopecia
Article | Year |
---|---|
Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward β-Oxidation.
Chemotherapy-induced alopecia (CIA) is a common side effect of conventional chemotherapy and represents a major problem in clinical oncology. Even months after the end of chemotherapy, many cancer patients complain of hair loss, a condition that is psychologically difficult to manage. CIA disturbs social and sexual interactions and causes anxiety and depression. Synthetic drugs protecting from CIA and endowed with hair growth stimulatory properties are prescribed with caution by oncologists. Hormones, growth factors, morphogens could unwontedly protect tumour cells or induce cancer cell proliferation and are thus considered incompatible with many chemotherapy regimens. Nutraceuticals, on the contrary, have been shown to be safe and effective treatment options for hair loss. We here show that polyphenols from Topics: Administration, Topical; Alopecia; Animals; Antineoplastic Agents; Bridged-Ring Compounds; Dietary Supplements; Dinoprost; Fatty Acids, Unsaturated; Hair Follicle; Keratins; Male; Malus; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Plant Extracts; Polyphenols; Taxoids | 2018 |
News, views and reviews.
Topics: Alopecia; Alprostadil; Dinoprost; Eyebrows; Humans; Prostaglandins | 2013 |